Research ArticleArticle
Open Access
Patients with Gout Treated with Conventional Urate-lowering Therapy: Association with Disease Control, Health-related Quality of Life, and Work Productivity
Robert Wood, Steve Fermer, Sulabha Ramachandran, Scott Baumgartner and Robert Morlock
The Journal of Rheumatology April 2016, jrheum.151199; DOI: https://doi.org/10.3899/jrheum.151199
Robert Wood
From Adelphi Real World, Cheshire, UK; AstraZeneca, Wilmington, Delaware; Ardea Biosciences Inc., San Diego, California, USA. R. Wood, BSc, Adelphi Real World; S. Fermer, Adelphi Real World; S. Ramachandran, PhD, former employee, AstraZeneca; S. Baumgartner, MD, Ardea Biosciences Inc.; R. Morlock, PhD, Ardea Biosciences Inc. Editorial support funded by AstraZeneca. Address correspondence to R. Wood, Adelphi Real World, Adelphi Mill, Macclesfield, Cheshire SK10 5JB, UK. E-mail: Robert.Wood@adelphigroup.com. Full Release Article. For details see Reprints/Permissions at jrheum.org. Accepted for publication February 23, 2016.
Steve Fermer
From Adelphi Real World, Cheshire, UK; AstraZeneca, Wilmington, Delaware; Ardea Biosciences Inc., San Diego, California, USA. R. Wood, BSc, Adelphi Real World; S. Fermer, Adelphi Real World; S. Ramachandran, PhD, former employee, AstraZeneca; S. Baumgartner, MD, Ardea Biosciences Inc.; R. Morlock, PhD, Ardea Biosciences Inc. Editorial support funded by AstraZeneca. Address correspondence to R. Wood, Adelphi Real World, Adelphi Mill, Macclesfield, Cheshire SK10 5JB, UK. E-mail: Robert.Wood@adelphigroup.com. Full Release Article. For details see Reprints/Permissions at jrheum.org. Accepted for publication February 23, 2016.
Sulabha Ramachandran
From Adelphi Real World, Cheshire, UK; AstraZeneca, Wilmington, Delaware; Ardea Biosciences Inc., San Diego, California, USA. R. Wood, BSc, Adelphi Real World; S. Fermer, Adelphi Real World; S. Ramachandran, PhD, former employee, AstraZeneca; S. Baumgartner, MD, Ardea Biosciences Inc.; R. Morlock, PhD, Ardea Biosciences Inc. Editorial support funded by AstraZeneca. Address correspondence to R. Wood, Adelphi Real World, Adelphi Mill, Macclesfield, Cheshire SK10 5JB, UK. E-mail: Robert.Wood@adelphigroup.com. Full Release Article. For details see Reprints/Permissions at jrheum.org. Accepted for publication February 23, 2016.
Scott Baumgartner
From Adelphi Real World, Cheshire, UK; AstraZeneca, Wilmington, Delaware; Ardea Biosciences Inc., San Diego, California, USA. R. Wood, BSc, Adelphi Real World; S. Fermer, Adelphi Real World; S. Ramachandran, PhD, former employee, AstraZeneca; S. Baumgartner, MD, Ardea Biosciences Inc.; R. Morlock, PhD, Ardea Biosciences Inc. Editorial support funded by AstraZeneca. Address correspondence to R. Wood, Adelphi Real World, Adelphi Mill, Macclesfield, Cheshire SK10 5JB, UK. E-mail: Robert.Wood@adelphigroup.com. Full Release Article. For details see Reprints/Permissions at jrheum.org. Accepted for publication February 23, 2016.
Robert Morlock
From Adelphi Real World, Cheshire, UK; AstraZeneca, Wilmington, Delaware; Ardea Biosciences Inc., San Diego, California, USA. R. Wood, BSc, Adelphi Real World; S. Fermer, Adelphi Real World; S. Ramachandran, PhD, former employee, AstraZeneca; S. Baumgartner, MD, Ardea Biosciences Inc.; R. Morlock, PhD, Ardea Biosciences Inc. Editorial support funded by AstraZeneca. Address correspondence to R. Wood, Adelphi Real World, Adelphi Mill, Macclesfield, Cheshire SK10 5JB, UK. E-mail: Robert.Wood@adelphigroup.com. Full Release Article. For details see Reprints/Permissions at jrheum.org. Accepted for publication February 23, 2016.
Published eLetters
eLetters are comments published online only and are not peer-reviewed. Publication of eLetter submissions is not guaranteed, and all submissions are reviewed and edited at the discretion of The Journal's staff.
If you wish to publish Letters to the Editor or Correspondence, please submit through our online submission system ScholarOne Manuscripts.
Jump to comment:
No eLetters have been published for this article.
In this issue
The Journal of Rheumatology
Vol. 51, Issue 4
1 Apr 2024
Patients with Gout Treated with Conventional Urate-lowering Therapy: Association with Disease Control, Health-related Quality of Life, and Work Productivity
Robert Wood, Steve Fermer, Sulabha Ramachandran, Scott Baumgartner, Robert Morlock
The Journal of Rheumatology Apr 2016, jrheum.151199; DOI: 10.3899/jrheum.151199
Patients with Gout Treated with Conventional Urate-lowering Therapy: Association with Disease Control, Health-related Quality of Life, and Work Productivity
Robert Wood, Steve Fermer, Sulabha Ramachandran, Scott Baumgartner, Robert Morlock
The Journal of Rheumatology Apr 2016, jrheum.151199; DOI: 10.3899/jrheum.151199